Role of Systemic Therapies in NMIBC with Dr. Amirali Salmasi, MD

11 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Amirali Salmasi, MD, MSCR, Associate Professor of Urology, University of California San Diego, La Jolla, California, explores the rationale for systemic immunotherapy in non-muscle invasive bladder cancer, emphasizing its potential role in BCG-unresponsive disease. In this 18-minute presentation, Dr. Salmasi shares that studies combining BCG with systemic immunotherapy suggest only marginal improvements, raising questions about its necessity for non-invasive tumors. The experts on the forum enhance the discussion.
Category
Oncology
Be the first to comment

Up Next